Novo Nordisk said that if approved for use ... and showed that it was equivalent to insulin glargine, another once-daily basal insulin, in glucose-lowering efficacy with a similar safety profile.

A patient advocacy group has started a campaign to stop Novo Nordisk from following through on a plan to stop making insulin product Levemir, arguing that it could leave some diabetics without an ...

Novo Nordisk provided three main reasons for ... including but not limited to Basaglar, Insulin Degludec, Insulin Glargine U-300, Lantus, Rezvoglar, Semglee, Toujeo and Tresiba.

Novo Nordisk joined the many pharmaceutical companies pushing back on government-negotiated drug pricing in the United States.

Currently, Civica is making a long-acting insulin called glargine, most commonly sold ... which Danish drugmaker Novo Nordisk produces under the brand name NovoLog. Eventually, Civica expects ...